12
Participants
Start Date
September 24, 2019
Primary Completion Date
December 19, 2019
Study Completion Date
December 19, 2019
PF-06700841
PF-06700841 oral tablets in 5mg and 25mg provided for a 30mg dose
Itraconazole
200 mg oral solution administered as 20 milliliters(mL) (10 mg/mL)
Pfizer New Haven Clinical Research Unit, New Haven
Lead Sponsor
Pfizer
INDUSTRY